Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials

By Shen Zhao, Ying Cheng, Qiming Wang, Xingya Li, Jun-Juan Liao, J. Rodon, Xiangjiao Meng, Yongzhong Luo, Zhendong Chen, Wei Wang and 21 more. 2025